| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Substitutes | 10 | 2002 | 57 | 1.350 |
Why?
|
| Mitral Valve Insufficiency | 24 | 2020 | 1401 | 1.260 |
Why?
|
| Coronary Artery Bypass | 19 | 2023 | 2188 | 1.170 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2022 | 1547 | 1.060 |
Why?
|
| Aortic Valve Stenosis | 13 | 2022 | 2002 | 1.010 |
Why?
|
| Cardiopulmonary Bypass | 11 | 2021 | 1093 | 1.000 |
Why?
|
| Aortic Valve | 14 | 2022 | 1950 | 0.950 |
Why?
|
| Heart Valve Prosthesis | 14 | 2022 | 1466 | 0.890 |
Why?
|
| Cardiac Surgical Procedures | 18 | 2021 | 3603 | 0.840 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2022 | 578 | 0.800 |
Why?
|
| Ultrafiltration | 1 | 2021 | 49 | 0.760 |
Why?
|
| Hemoglobins | 11 | 2002 | 1518 | 0.730 |
Why?
|
| Ventricular Function, Right | 7 | 2002 | 609 | 0.710 |
Why?
|
| Ventricular Dysfunction, Right | 5 | 2012 | 615 | 0.680 |
Why?
|
| Lightning | 1 | 2019 | 5 | 0.670 |
Why?
|
| Mitral Valve | 17 | 2019 | 1466 | 0.640 |
Why?
|
| Heart Valve Diseases | 6 | 2019 | 1033 | 0.600 |
Why?
|
| Heart Arrest, Induced | 1 | 2019 | 357 | 0.600 |
Why?
|
| Endocarditis | 4 | 2019 | 349 | 0.570 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 632 | 0.560 |
Why?
|
| Sternum | 2 | 2017 | 175 | 0.550 |
Why?
|
| Cardiomyopathy, Hypertrophic | 11 | 2018 | 1309 | 0.550 |
Why?
|
| Aortic Diseases | 2 | 2020 | 735 | 0.510 |
Why?
|
| Ventricular Remodeling | 10 | 2017 | 1256 | 0.510 |
Why?
|
| Hematoma | 1 | 2020 | 768 | 0.500 |
Why?
|
| Defibrillators, Implantable | 12 | 2015 | 1487 | 0.480 |
Why?
|
| Endocarditis, Bacterial | 4 | 2016 | 442 | 0.470 |
Why?
|
| Pericardium | 9 | 2010 | 675 | 0.470 |
Why?
|
| Coronary Vessels | 7 | 2023 | 3072 | 0.460 |
Why?
|
| Dogs | 35 | 2002 | 3838 | 0.450 |
Why?
|
| IgA Deficiency | 1 | 2013 | 43 | 0.440 |
Why?
|
| Diabetes Complications | 1 | 2020 | 1317 | 0.440 |
Why?
|
| Blood Component Transfusion | 2 | 2013 | 141 | 0.430 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 218 | 0.430 |
Why?
|
| Coronary Circulation | 15 | 1999 | 1561 | 0.430 |
Why?
|
| Sarcoma | 2 | 2019 | 1784 | 0.430 |
Why?
|
| Heart Septum | 5 | 2006 | 303 | 0.410 |
Why?
|
| Aortic Aneurysm | 6 | 2022 | 648 | 0.410 |
Why?
|
| Hypertension, Pulmonary | 8 | 2021 | 1565 | 0.370 |
Why?
|
| Thoracic Surgery | 2 | 2016 | 722 | 0.360 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2010 | 59 | 0.350 |
Why?
|
| Myocardial Infarction | 12 | 2022 | 11422 | 0.350 |
Why?
|
| Hemophilia A | 1 | 2013 | 359 | 0.340 |
Why?
|
| Coronary Disease | 15 | 2004 | 5915 | 0.330 |
Why?
|
| Hemodynamics | 20 | 2017 | 4156 | 0.330 |
Why?
|
| Postoperative Complications | 29 | 2021 | 15532 | 0.320 |
Why?
|
| Myocardium | 8 | 2019 | 4690 | 0.320 |
Why?
|
| Chitosan | 1 | 2010 | 130 | 0.320 |
Why?
|
| Sheep | 19 | 2015 | 1439 | 0.320 |
Why?
|
| Ventricular Function, Left | 13 | 2022 | 3858 | 0.320 |
Why?
|
| Myocardial Ischemia | 9 | 2013 | 2109 | 0.300 |
Why?
|
| Blood Transfusion | 7 | 2001 | 1295 | 0.290 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 5105 | 0.290 |
Why?
|
| Polyvinyl Alcohol | 3 | 2015 | 73 | 0.280 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2006 | 29 | 0.270 |
Why?
|
| Endarterectomy | 2 | 2017 | 195 | 0.260 |
Why?
|
| Aprotinin | 1 | 2006 | 94 | 0.260 |
Why?
|
| Oxygen | 10 | 2001 | 4190 | 0.240 |
Why?
|
| Papillary Muscles | 5 | 2010 | 192 | 0.230 |
Why?
|
| Heart-Lung Machine | 1 | 2004 | 44 | 0.230 |
Why?
|
| Blood Loss, Surgical | 2 | 2013 | 636 | 0.230 |
Why?
|
| Ventricular Function | 3 | 2006 | 406 | 0.230 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 360 | 0.230 |
Why?
|
| Heart-Assist Devices | 5 | 2012 | 1279 | 0.220 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6364 | 0.220 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 1945 | 0.220 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2012 | 864 | 0.210 |
Why?
|
| Humans | 116 | 2023 | 757566 | 0.210 |
Why?
|
| Antifibrinolytic Agents | 1 | 2006 | 292 | 0.210 |
Why?
|
| Heart Diseases | 4 | 2010 | 2781 | 0.200 |
Why?
|
| Heart Transplantation | 6 | 2002 | 3220 | 0.200 |
Why?
|
| Sclerosing Solutions | 3 | 2006 | 79 | 0.200 |
Why?
|
| Echocardiography, Three-Dimensional | 10 | 2012 | 606 | 0.200 |
Why?
|
| Tachycardia, Ventricular | 5 | 2009 | 1297 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2012 | 1088 | 0.190 |
Why?
|
| Ethanol | 5 | 2009 | 1324 | 0.180 |
Why?
|
| Heart Failure | 11 | 2020 | 11595 | 0.180 |
Why?
|
| Aorta | 6 | 2020 | 2037 | 0.180 |
Why?
|
| Hyaluronic Acid | 2 | 1994 | 482 | 0.180 |
Why?
|
| Pulmonary Embolism | 4 | 2021 | 2540 | 0.180 |
Why?
|
| Thorax | 1 | 2023 | 553 | 0.180 |
Why?
|
| Myocardial Revascularization | 3 | 2022 | 792 | 0.170 |
Why?
|
| Aorta, Thoracic | 3 | 1995 | 1094 | 0.170 |
Why?
|
| Treatment Outcome | 24 | 2022 | 64242 | 0.170 |
Why?
|
| Ventricular Pressure | 4 | 2002 | 204 | 0.170 |
Why?
|
| Mortality | 2 | 2021 | 2882 | 0.170 |
Why?
|
| Polymers | 4 | 2017 | 1612 | 0.170 |
Why?
|
| Echocardiography | 11 | 2018 | 4963 | 0.160 |
Why?
|
| Calcium Chloride | 2 | 1998 | 78 | 0.160 |
Why?
|
| Thoracotomy | 3 | 2017 | 363 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2022 | 308 | 0.160 |
Why?
|
| Pacemaker, Artificial | 6 | 2015 | 808 | 0.160 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2001 | 130 | 0.160 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2020 | 144 | 0.150 |
Why?
|
| Bundle-Branch Block | 3 | 2016 | 278 | 0.150 |
Why?
|
| Splanchnic Circulation | 1 | 1998 | 110 | 0.150 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2017 | 30 | 0.150 |
Why?
|
| Animals | 63 | 2020 | 167718 | 0.150 |
Why?
|
| Thymus Gland | 1 | 2002 | 1240 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 1 | 2002 | 562 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2017 | 2115 | 0.140 |
Why?
|
| Transplantation, Heterotopic | 1 | 1997 | 174 | 0.140 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2018 | 272 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1923 | 0.140 |
Why?
|
| Tissue Adhesions | 3 | 2010 | 218 | 0.130 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2016 | 41 | 0.130 |
Why?
|
| Male | 85 | 2022 | 358180 | 0.130 |
Why?
|
| Learning Curve | 1 | 2017 | 229 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 435 | 0.130 |
Why?
|
| Endarterectomy, Carotid | 2 | 2005 | 549 | 0.130 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2002 | 1731 | 0.130 |
Why?
|
| Blood | 1 | 1998 | 584 | 0.130 |
Why?
|
| Models, Cardiovascular | 3 | 1997 | 970 | 0.130 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2007 | 189 | 0.130 |
Why?
|
| Transplantation, Homologous | 3 | 2008 | 4808 | 0.130 |
Why?
|
| Hemothorax | 1 | 2015 | 57 | 0.130 |
Why?
|
| Hematocrit | 5 | 2002 | 625 | 0.130 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2015 | 82 | 0.120 |
Why?
|
| Mannitol | 3 | 1989 | 180 | 0.120 |
Why?
|
| Stroke Volume | 9 | 2022 | 5461 | 0.120 |
Why?
|
| Surgical Mesh | 1 | 2017 | 310 | 0.120 |
Why?
|
| Stents | 3 | 2003 | 3162 | 0.120 |
Why?
|
| Urticaria | 1 | 2015 | 150 | 0.110 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 2113 | 0.110 |
Why?
|
| Ventricular Fibrillation | 3 | 2009 | 537 | 0.110 |
Why?
|
| Prosthesis Failure | 4 | 2015 | 1197 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2016 | 208 | 0.110 |
Why?
|
| Heart Aneurysm | 1 | 1994 | 114 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 820 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 1997 | 679 | 0.110 |
Why?
|
| Norepinephrine | 3 | 1995 | 897 | 0.110 |
Why?
|
| Heart, Artificial | 2 | 2004 | 107 | 0.110 |
Why?
|
| Aged | 48 | 2021 | 167890 | 0.110 |
Why?
|
| Myocardial Contraction | 6 | 2006 | 1516 | 0.110 |
Why?
|
| Pericardial Effusion | 1 | 2015 | 247 | 0.110 |
Why?
|
| Bronchial Neoplasms | 1 | 2013 | 110 | 0.110 |
Why?
|
| Heart Ventricles | 8 | 2017 | 3806 | 0.110 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1995 | 261 | 0.110 |
Why?
|
| Blood Pressure | 8 | 2012 | 8453 | 0.100 |
Why?
|
| Heart | 5 | 2023 | 4382 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1011 | 0.100 |
Why?
|
| Intracranial Pressure | 1 | 1995 | 324 | 0.100 |
Why?
|
| Tetralogy of Fallot | 2 | 1988 | 631 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 824 | 0.100 |
Why?
|
| Oxygen Consumption | 6 | 1998 | 1846 | 0.100 |
Why?
|
| Time Factors | 18 | 2021 | 39811 | 0.100 |
Why?
|
| Microspheres | 3 | 1993 | 787 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 1994 | 365 | 0.100 |
Why?
|
| Cattle | 5 | 2002 | 3846 | 0.100 |
Why?
|
| Dyspnea | 3 | 2016 | 1344 | 0.100 |
Why?
|
| Aortic Rupture | 1 | 1995 | 315 | 0.100 |
Why?
|
| Blood Donors | 1 | 1994 | 343 | 0.100 |
Why?
|
| Graft Survival | 1 | 2002 | 3794 | 0.100 |
Why?
|
| Female | 76 | 2022 | 389943 | 0.100 |
Why?
|
| Cold Temperature | 1 | 2015 | 780 | 0.100 |
Why?
|
| Postoperative Hemorrhage | 3 | 2006 | 412 | 0.100 |
Why?
|
| Chest Pain | 2 | 2016 | 1090 | 0.100 |
Why?
|
| Anesthesia Recovery Period | 1 | 2012 | 155 | 0.100 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 255 | 0.090 |
Why?
|
| Follow-Up Studies | 21 | 2014 | 39020 | 0.090 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 161 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.090 |
Why?
|
| Postoperative Care | 3 | 2017 | 1468 | 0.090 |
Why?
|
| Oxygenators | 2 | 2002 | 36 | 0.090 |
Why?
|
| Risk Factors | 22 | 2022 | 73708 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2006 | 4673 | 0.090 |
Why?
|
| Aged, 80 and over | 20 | 2022 | 58558 | 0.090 |
Why?
|
| Pericardial Window Techniques | 1 | 2009 | 10 | 0.090 |
Why?
|
| Action Potentials | 1 | 2017 | 1816 | 0.090 |
Why?
|
| Postpericardiotomy Syndrome | 1 | 2009 | 11 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 1992 | 223 | 0.090 |
Why?
|
| Plasma Substitutes | 1 | 1989 | 57 | 0.090 |
Why?
|
| Solutions | 3 | 1998 | 411 | 0.090 |
Why?
|
| Mitral Valve Stenosis | 1 | 2012 | 345 | 0.090 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 128 | 0.090 |
Why?
|
| Regional Blood Flow | 5 | 1998 | 1485 | 0.090 |
Why?
|
| Catheterization | 1 | 1995 | 1426 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 1997 | 2378 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1472 | 0.080 |
Why?
|
| Cryosurgery | 1 | 1994 | 474 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2009 | 1553 | 0.080 |
Why?
|
| Risk Assessment | 8 | 2019 | 23816 | 0.080 |
Why?
|
| Bioprosthesis | 4 | 2002 | 591 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2717 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 1655 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 1989 | 292 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2017 | 352 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 15774 | 0.080 |
Why?
|
| Pneumonectomy | 2 | 2013 | 1110 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2412 | 0.080 |
Why?
|
| Carotid Stenosis | 1 | 1995 | 853 | 0.080 |
Why?
|
| Tracheal Stenosis | 2 | 2002 | 226 | 0.070 |
Why?
|
| Heart Injuries | 1 | 2009 | 205 | 0.070 |
Why?
|
| Intraoperative Complications | 3 | 2003 | 1165 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 4 | 1995 | 1628 | 0.070 |
Why?
|
| Endocardial Cushion Defects | 1 | 1987 | 43 | 0.070 |
Why?
|
| Shock, Cardiogenic | 3 | 2004 | 707 | 0.070 |
Why?
|
| Blood Vessel Prosthesis | 4 | 1999 | 953 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2013 | 1150 | 0.070 |
Why?
|
| Consensus | 1 | 2016 | 3097 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1998 | 1452 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2009 | 247 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1629 | 0.070 |
Why?
|
| Survival Analysis | 9 | 2009 | 10075 | 0.070 |
Why?
|
| Pancreas | 1 | 1993 | 1676 | 0.070 |
Why?
|
| Chordae Tendineae | 1 | 2006 | 39 | 0.070 |
Why?
|
| Blood Volume | 2 | 2002 | 548 | 0.070 |
Why?
|
| Middle Aged | 45 | 2018 | 219192 | 0.070 |
Why?
|
| Omentum | 2 | 2003 | 168 | 0.070 |
Why?
|
| Pulmonary Artery | 5 | 2021 | 1916 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 2140 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2010 | 1746 | 0.070 |
Why?
|
| Rats, Inbred Strains | 2 | 2002 | 2090 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 6 | 2002 | 223 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2008 | 555 | 0.070 |
Why?
|
| Vasodilation | 4 | 1994 | 960 | 0.070 |
Why?
|
| Heart Septal Defects | 1 | 1987 | 191 | 0.060 |
Why?
|
| Retrospective Studies | 25 | 2021 | 79984 | 0.060 |
Why?
|
| Length of Stay | 7 | 2020 | 6384 | 0.060 |
Why?
|
| Echocardiography, Doppler | 4 | 2012 | 898 | 0.060 |
Why?
|
| Actuarial Analysis | 7 | 2005 | 374 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2021 | 4777 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2020 | 3241 | 0.060 |
Why?
|
| Mitral Valve Prolapse | 1 | 2007 | 214 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 1994 | 1686 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 15781 | 0.060 |
Why?
|
| Cardiac Output | 3 | 2006 | 837 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 292 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 1996 | 1415 | 0.060 |
Why?
|
| Hospital Mortality | 9 | 2020 | 5243 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2006 | 180 | 0.060 |
Why?
|
| Hydrogels | 1 | 2010 | 722 | 0.060 |
Why?
|
| Survival Rate | 11 | 2015 | 12684 | 0.060 |
Why?
|
| Abscess | 1 | 2008 | 605 | 0.060 |
Why?
|
| Injections | 3 | 2015 | 829 | 0.060 |
Why?
|
| Heart Block | 1 | 2005 | 392 | 0.060 |
Why?
|
| Multivariate Analysis | 9 | 2021 | 12047 | 0.060 |
Why?
|
| Hemodilution | 2 | 1995 | 120 | 0.050 |
Why?
|
| Surgical Wound Infection | 3 | 2002 | 1521 | 0.050 |
Why?
|
| Prognosis | 10 | 2019 | 29488 | 0.050 |
Why?
|
| Sympatholytics | 1 | 1982 | 82 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2013 | 2904 | 0.050 |
Why?
|
| Exchange Transfusion, Whole Blood | 2 | 1995 | 59 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20499 | 0.050 |
Why?
|
| Chronic Disease | 6 | 2021 | 9263 | 0.050 |
Why?
|
| Adult | 25 | 2019 | 219725 | 0.050 |
Why?
|
| Cardiac Tamponade | 1 | 2003 | 175 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 793 | 0.050 |
Why?
|
| Heart Arrest | 3 | 2002 | 1494 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2002 | 776 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 839 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6470 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 13952 | 0.050 |
Why?
|
| Heart Atria | 2 | 2006 | 1344 | 0.050 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2001 | 26 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2004 | 895 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9245 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2021 | 5951 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12951 | 0.040 |
Why?
|
| Reoperation | 8 | 2005 | 4279 | 0.040 |
Why?
|
| Electrocardiography | 6 | 2018 | 6363 | 0.040 |
Why?
|
| Vascular Resistance | 3 | 1995 | 930 | 0.040 |
Why?
|
| Cohort Studies | 7 | 2022 | 41190 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2001 | 2246 | 0.040 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2003 | 348 | 0.040 |
Why?
|
| Adenosine | 2 | 1987 | 802 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 1989 | 2082 | 0.040 |
Why?
|
| Methemoglobin | 1 | 1998 | 25 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 372 | 0.040 |
Why?
|
| Surgical Flaps | 2 | 2003 | 1669 | 0.040 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18114 | 0.040 |
Why?
|
| Device Removal | 1 | 2003 | 629 | 0.040 |
Why?
|
| Chromonar | 3 | 1994 | 4 | 0.040 |
Why?
|
| Partial Pressure | 1 | 1998 | 245 | 0.040 |
Why?
|
| Treatment Failure | 3 | 2006 | 2637 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2017 | 50 | 0.040 |
Why?
|
| Electric Countershock | 2 | 1993 | 533 | 0.040 |
Why?
|
| Death | 1 | 2022 | 674 | 0.040 |
Why?
|
| Rats | 4 | 2002 | 23676 | 0.040 |
Why?
|
| Veins | 1 | 2002 | 764 | 0.040 |
Why?
|
| Digestive System | 1 | 1998 | 244 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2018 | 320 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2017 | 2969 | 0.040 |
Why?
|
| Logistic Models | 4 | 2016 | 13221 | 0.040 |
Why?
|
| Trachea | 2 | 2002 | 1082 | 0.040 |
Why?
|
| Anemia | 2 | 2002 | 1503 | 0.040 |
Why?
|
| Disease Management | 1 | 2008 | 2495 | 0.040 |
Why?
|
| Acute Disease | 5 | 2016 | 7225 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2009 | 2248 | 0.030 |
Why?
|
| Linear Models | 2 | 2017 | 5856 | 0.030 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2001 | 353 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 1999 | 1370 | 0.030 |
Why?
|
| Swine | 2 | 1997 | 5891 | 0.030 |
Why?
|
| Equipment Design | 3 | 2017 | 3502 | 0.030 |
Why?
|
| Phenylephrine | 3 | 1982 | 293 | 0.030 |
Why?
|
| Prosthesis Implantation | 2 | 2015 | 590 | 0.030 |
Why?
|
| Cyanosis | 1 | 1996 | 86 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2005 | 8512 | 0.030 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 1999 | 695 | 0.030 |
Why?
|
| Methemoglobinemia | 1 | 1995 | 44 | 0.030 |
Why?
|
| Constriction | 1 | 1995 | 171 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 529 | 0.030 |
Why?
|
| Prosthesis Design | 3 | 2012 | 2105 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1994 | 105 | 0.030 |
Why?
|
| Diastole | 2 | 1994 | 781 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 2152 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 1998 | 1111 | 0.030 |
Why?
|
| Erythropoietin | 1 | 1997 | 719 | 0.030 |
Why?
|
| Postoperative Period | 3 | 1993 | 1806 | 0.030 |
Why?
|
| Pancreatitis | 2 | 1991 | 1096 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2016 | 9624 | 0.030 |
Why?
|
| Endocardium | 1 | 1994 | 246 | 0.030 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 12397 | 0.030 |
Why?
|
| Amylases | 2 | 1991 | 169 | 0.030 |
Why?
|
| Registries | 2 | 2020 | 8164 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1995 | 460 | 0.030 |
Why?
|
| Electrophysiology | 2 | 1993 | 1263 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1554 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 10135 | 0.030 |
Why?
|
| Vasoconstriction | 2 | 1993 | 592 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 543 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2012 | 1240 | 0.030 |
Why?
|
| Tachycardia | 1 | 1994 | 600 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 984 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1997 | 1475 | 0.020 |
Why?
|
| Perfusion | 2 | 1995 | 1374 | 0.020 |
Why?
|
| Cardiac Output, Low | 2 | 1983 | 191 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1992 | 141 | 0.020 |
Why?
|
| Cause of Death | 6 | 2001 | 3667 | 0.020 |
Why?
|
| Haplotypes | 1 | 2018 | 2764 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 3415 | 0.020 |
Why?
|
| Paraplegia | 1 | 1992 | 162 | 0.020 |
Why?
|
| Recurrence | 4 | 2008 | 8426 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2003 | 213 | 0.020 |
Why?
|
| Incidence | 4 | 2015 | 21217 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1994 | 491 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 688 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 1992 | 217 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12261 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1992 | 672 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15207 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1886 | 0.020 |
Why?
|
| Catheter Ablation | 3 | 2009 | 2741 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 2100 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 1972 | 223 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 1296 | 0.020 |
Why?
|
| Hypertension | 2 | 1981 | 8502 | 0.020 |
Why?
|
| Dipyridamole | 1 | 1989 | 140 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6230 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1567 | 0.020 |
Why?
|
| Fontan Procedure | 1 | 1996 | 791 | 0.020 |
Why?
|
| Pericardiectomy | 1 | 2009 | 46 | 0.020 |
Why?
|
| Biological Transport | 1 | 1994 | 2081 | 0.020 |
Why?
|
| Particle Size | 1 | 1993 | 1640 | 0.020 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1999 | 1427 | 0.020 |
Why?
|
| Pulmonary Circulation | 2 | 1993 | 743 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2212 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
| Methyltransferases | 1 | 1972 | 374 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2564 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2190 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1649 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1989 | 292 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1989 | 660 | 0.020 |
Why?
|
| Nitroglycerin | 1 | 1989 | 328 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 2 | 2006 | 939 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1995 | 1434 | 0.020 |
Why?
|
| United States | 1 | 2016 | 71902 | 0.020 |
Why?
|
| Pressure | 3 | 2006 | 1154 | 0.020 |
Why?
|
| Half-Life | 1 | 1989 | 652 | 0.020 |
Why?
|
| Comorbidity | 2 | 2008 | 10477 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 1987 | 100 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1982 | 747 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 419 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 1143 | 0.020 |
Why?
|
| Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
| Resuscitation | 1 | 1992 | 661 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2008 | 194 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1991 | 1055 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1995 | 1815 | 0.020 |
Why?
|
| Systole | 2 | 1995 | 935 | 0.020 |
Why?
|
| Polysaccharides | 1 | 1973 | 1007 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1527 | 0.020 |
Why?
|
| Polycythemia | 1 | 1987 | 125 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1863 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 2992 | 0.020 |
Why?
|
| Boston | 2 | 2015 | 9298 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 755 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1992 | 831 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1170 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1992 | 936 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2006 | 277 | 0.020 |
Why?
|
| Debridement | 1 | 2008 | 492 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1992 | 794 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 392 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3591 | 0.020 |
Why?
|
| Dependovirus | 1 | 2010 | 711 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 1203 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1994 | 2411 | 0.010 |
Why?
|
| Gestational Age | 1 | 2013 | 3565 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1987 | 408 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1994 | 6337 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13597 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1981 | 2496 | 0.010 |
Why?
|
| Cardiac Volume | 2 | 2001 | 199 | 0.010 |
Why?
|
| Hypotension, Controlled | 1 | 1983 | 16 | 0.010 |
Why?
|
| Creatinine | 1 | 1989 | 1892 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2110 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2131 | 0.010 |
Why?
|
| Infant | 5 | 2002 | 36045 | 0.010 |
Why?
|
| Constriction, Pathologic | 2 | 1993 | 1097 | 0.010 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3579 | 0.010 |
Why?
|
| Adolescent | 7 | 2006 | 87819 | 0.010 |
Why?
|
| Physiology | 1 | 1984 | 111 | 0.010 |
Why?
|
| Wounds, Gunshot | 1 | 2009 | 581 | 0.010 |
Why?
|
| Cell Line | 1 | 2017 | 15587 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 2003 | 93 | 0.010 |
Why?
|
| Staphylococcal Infections | 2 | 2006 | 1406 | 0.010 |
Why?
|
| Electrodes, Implanted | 3 | 1993 | 833 | 0.010 |
Why?
|
| Mediastinitis | 1 | 2003 | 49 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 829 | 0.010 |
Why?
|
| Patient Selection | 2 | 2007 | 4235 | 0.010 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2003 | 49 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8815 | 0.010 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.010 |
Why?
|
| Esophageal Perforation | 1 | 2003 | 65 | 0.010 |
Why?
|
| Equipment Safety | 1 | 2004 | 249 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1982 | 182 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1984 | 495 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2922 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 1870 | 0.010 |
Why?
|
| Forecasting | 3 | 1998 | 2919 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1903 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1982 | 174 | 0.010 |
Why?
|
| Renal Insufficiency | 2 | 1998 | 809 | 0.010 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1982 | 177 | 0.010 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1982 | 172 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1982 | 246 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36270 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1993 | 10749 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4110 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 1664 | 0.010 |
Why?
|
| Chemistry | 1 | 1981 | 348 | 0.010 |
Why?
|
| Propranolol | 1 | 1982 | 489 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1981 | 508 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 2003 | 265 | 0.010 |
Why?
|
| Syncope | 1 | 2003 | 427 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2847 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2006 | 995 | 0.010 |
Why?
|
| Freezing | 1 | 1981 | 305 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1981 | 377 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1980 | 249 | 0.010 |
Why?
|
| Catecholamines | 1 | 1980 | 385 | 0.010 |
Why?
|
| Prospective Studies | 6 | 2008 | 54092 | 0.010 |
Why?
|
| Lung | 2 | 2016 | 9973 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5778 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15640 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14637 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11082 | 0.010 |
Why?
|
| Insulin | 1 | 1973 | 6578 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1991 | 4427 | 0.010 |
Why?
|
| Lipase | 2 | 1991 | 324 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1977 | 82 | 0.010 |
Why?
|
| Epoetin Alfa | 1 | 1997 | 78 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1977 | 306 | 0.010 |
Why?
|
| Drainage | 1 | 2003 | 1155 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2868 | 0.010 |
Why?
|
| Hyperemia | 1 | 1979 | 221 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 1748 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1977 | 394 | 0.010 |
Why?
|
| Corynebacterium Infections | 1 | 1997 | 27 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1982 | 911 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 8946 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2782 | 0.010 |
Why?
|
| Laser Therapy | 1 | 2003 | 1082 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1992 | 4314 | 0.010 |
Why?
|
| Dextrocardia | 1 | 1996 | 37 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2001 | 640 | 0.010 |
Why?
|
| Methods | 1 | 1996 | 1074 | 0.010 |
Why?
|
| Situs Inversus | 1 | 1996 | 62 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2742 | 0.010 |
Why?
|
| Aorta, Abdominal | 2 | 1991 | 625 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3757 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 112 | 0.010 |
Why?
|
| Replantation | 1 | 1997 | 145 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1981 | 1627 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2008 | 22022 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1980 | 756 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5720 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 1998 | 323 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2003 | 1184 | 0.010 |
Why?
|
| Candidiasis | 1 | 1997 | 363 | 0.010 |
Why?
|
| Models, Biological | 1 | 1990 | 9459 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2002 | 1160 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2003 | 1306 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 29712 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1973 | 157 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1996 | 979 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1972 | 76 | 0.010 |
Why?
|
| Radiation Effects | 1 | 1972 | 69 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1972 | 93 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1997 | 616 | 0.010 |
Why?
|
| Sex Factors | 2 | 1998 | 10495 | 0.010 |
Why?
|
| Isoamylase | 1 | 1991 | 10 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 320 | 0.010 |
Why?
|
| Wound Healing | 1 | 2003 | 2781 | 0.010 |
Why?
|
| Mathematics | 2 | 1984 | 707 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4451 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 1125 | 0.010 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1994 | 488 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 1992 | 112 | 0.010 |
Why?
|
| Lactates | 2 | 1983 | 404 | 0.010 |
Why?
|
| Polyethylene Terephthalates | 1 | 1991 | 115 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 458 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1972 | 532 | 0.010 |
Why?
|
| Carotid Artery Diseases | 1 | 1997 | 872 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2002 | 1915 | 0.010 |
Why?
|
| Pineal Gland | 1 | 1972 | 157 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2002 | 42045 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 1992 | 165 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 1972 | 213 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81066 | 0.010 |
Why?
|
| Acetates | 1 | 1972 | 321 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2295 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 1993 | 1153 | 0.010 |
Why?
|
| Iliac Artery | 1 | 1991 | 342 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 3261 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2420 | 0.010 |
Why?
|
| Manganese | 1 | 1972 | 395 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2002 | 26176 | 0.000 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1995 | 1044 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1997 | 2024 | 0.000 |
Why?
|
| Vasodilator Agents | 1 | 1993 | 973 | 0.000 |
Why?
|
| Magnesium | 1 | 1972 | 809 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1994 | 2357 | 0.000 |
Why?
|
| Hospitalization | 2 | 1998 | 10634 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6525 | 0.000 |
Why?
|
| Bronchial Fistula | 1 | 1988 | 83 | 0.000 |
Why?
|
| Zinc | 1 | 1972 | 687 | 0.000 |
Why?
|
| Reproducibility of Results | 2 | 1997 | 20037 | 0.000 |
Why?
|
| Mediastinal Diseases | 1 | 1988 | 91 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1997 | 1908 | 0.000 |
Why?
|
| Pleural Diseases | 1 | 1988 | 137 | 0.000 |
Why?
|
| Serotonin | 1 | 1972 | 1040 | 0.000 |
Why?
|
| Blood Viscosity | 1 | 1987 | 124 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1991 | 824 | 0.000 |
Why?
|
| Amiodarone | 1 | 1988 | 216 | 0.000 |
Why?
|
| Safety | 1 | 1991 | 1147 | 0.000 |
Why?
|
| Probability | 1 | 1992 | 2462 | 0.000 |
Why?
|
| Disease Progression | 1 | 2003 | 13463 | 0.000 |
Why?
|
| Fistula | 1 | 1988 | 212 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1972 | 3593 | 0.000 |
Why?
|
| Heart Rate | 1 | 1977 | 4172 | 0.000 |
Why?
|
| Light | 1 | 1972 | 1344 | 0.000 |
Why?
|
| Equipment Failure | 1 | 1988 | 577 | 0.000 |
Why?
|
| Age Factors | 1 | 2002 | 18326 | 0.000 |
Why?
|
| Emergencies | 1 | 1992 | 1209 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 3440 | 0.000 |
Why?
|
| Homeostasis | 2 | 1987 | 3299 | 0.000 |
Why?
|
| Aortography | 1 | 1986 | 420 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1992 | 1399 | 0.000 |
Why?
|
| Trimethaphan | 1 | 1983 | 11 | 0.000 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1983 | 66 | 0.000 |
Why?
|
| Indoles | 1 | 1972 | 1824 | 0.000 |
Why?
|
| Halothane | 1 | 1983 | 200 | 0.000 |
Why?
|
| Iron | 1 | 1972 | 1785 | 0.000 |
Why?
|
| Technetium | 1 | 1983 | 321 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 58755 | 0.000 |
Why?
|
| Hydrostatic Pressure | 1 | 1982 | 95 | 0.000 |
Why?
|
| Stroke | 1 | 2004 | 9695 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1983 | 588 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 6956 | 0.000 |
Why?
|
| Child | 2 | 2002 | 79782 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1983 | 1976 | 0.000 |
Why?
|
| Peptides | 1 | 1991 | 4338 | 0.000 |
Why?
|
| Uterus | 1 | 1982 | 649 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1992 | 3732 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1983 | 1133 | 0.000 |
Why?
|
| Epinephrine | 1 | 1980 | 790 | 0.000 |
Why?
|
| Liver | 1 | 1992 | 7502 | 0.000 |
Why?
|
| Dopamine | 1 | 1980 | 1599 | 0.000 |
Why?
|
| Anesthesia | 1 | 1982 | 1581 | 0.000 |
Why?
|